Progress in the study of plasma-drug concentration of imatinib for treatment of chronic myeloid leukemia.
- Author:
Li ZHOU
;
Zhi-xiang SHEN
- Publication Type:Journal Article
- MeSH: Benzamides; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; blood; drug therapy; Piperazines; pharmacokinetics; therapeutic use; Pyrimidines; pharmacokinetics; therapeutic use
- From: Chinese Journal of Hematology 2012;33(1):69-70
- CountryChina
- Language:Chinese